An investigation into the digestion of chitosan (noncrosslinked and crosslinked) by human colonic bacteria

被引:80
作者
Mcconnell, Emma L. [1 ]
Murdan, Sudaxshina [1 ]
Basit, Abdul W. [1 ]
机构
[1] Univ London, Sch Pharm, London WC1N 1AX, England
关键词
chitosan; anaerobic; microflora; fermentation; metabolism; large intestine; chitin;
D O I
10.1002/jps.21271
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chitosan salts are being investigated as materials for bacterially triggered colonic drug delivery, via the oral route, based on the assumption that they will be degraded by the enzymes produced by the human colonic bacteria. The actual susceptibility of chitosan to these enzymes is, however, unclear. The digestion of chitosan films (noncrosslinked, and crosslinked with glutaraldehyde or tripolyphosphate) by human colonic bacteria (using human faecal material) was therefore investigated, and in addition, their digestion by pancreatic enzymes (of porcine origin) was assessed. Noncrosslinked chitosan films were digested by both pancreatic and colonic enzymes within 4 h, while glutaraldehyde crosslinked chitosan films were resistant to both enzyme systems. In contrast, tripolyphosphate crosslinked chitosan films resisted pancreatic digestion, but were susceptible to faecal digestion over the same 4 h time period. As expected, lowering crosslinker concentration and increasing incubation time (to 18 h) allowed greater digestion. The difference between the crosslinkers is attributed to the mechanism of crosslinking, and the associated degree of film swelling in an aqueous environment, Swelling studies in acidic conditions suggest that only glutaraldehyde or higher concentrations of tripolyphosphate would be able to prevent film dissolution in gastric conditions. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 97:3820-3829, 2008.
引用
收藏
页码:3820 / 3829
页数:10
相关论文
共 50 条
[21]  
Jones DS., 2002, PHARM STAT
[22]   Preparation and characterization of chitosan microparticles intended for controlled drug delivery [J].
Ko, JA ;
Park, HJ ;
Hwang, SJ ;
Park, JB ;
Lee, JS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 249 (1-2) :165-174
[23]   Design of microencapsulated chitosan microspheres for colonic drug delivery [J].
Lorenzo-Lamosa, ML ;
Remunan-Lopez, C ;
Vila-Jato, JL ;
Alonso, MJ .
JOURNAL OF CONTROLLED RELEASE, 1998, 52 (1-2) :109-118
[24]   STARCH UTILIZATION BY THE HUMAN LARGE INTESTINAL MICROFLORA [J].
MACFARLANE, GT ;
ENGLYST, HN .
JOURNAL OF APPLIED BACTERIOLOGY, 1986, 60 (03) :195-201
[25]   Colonic drug delivery using amylose films: the role of aqueous ethylcellulose dispersions in controlling drug release [J].
McConnell, Emma L. ;
Tutas, Juned ;
Mohamed, Mohamed A. M. ;
Banning, Douglas ;
Basit, Abdul W. .
CELLULOSE, 2007, 14 (01) :25-34
[26]   Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using 5-aminosalicylic acid pellets [J].
Milojevic, S ;
Newton, JM ;
Cummings, JH ;
Gibson, GR ;
Botham, RL ;
Ring, SG ;
Stockham, M ;
Allwood, C .
JOURNAL OF CONTROLLED RELEASE, 1996, 38 (01) :75-84
[27]   Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using glucose pellets [J].
Milojevic, S ;
Newton, JM ;
Cummings, JH ;
Gibson, GR ;
Botham, RL ;
Ring, SG ;
Stockham, M ;
Allwood, MC .
JOURNAL OF CONTROLLED RELEASE, 1996, 38 (01) :85-94
[28]   Fermentation of carbohydrate in rat ileal excreta is enhanced with cecal inocula compared with fecal inocula [J].
Monsma, DJ ;
Marlett, JA .
JOURNAL OF NUTRITION, 1996, 126 (02) :554-563
[29]   Some studies of crosslinking chitosan-glutaraldehyde interaction in a homogeneous system [J].
Monteiro, OAC ;
Airoldi, C .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1999, 26 (2-3) :119-128
[30]   Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate? [J].
Morrison, Douglas J. ;
Mackay, William G. ;
Edwards, Christine A. ;
Preston, Tom ;
Dodson, Brian ;
Weaver, Lawrence T. .
BRITISH JOURNAL OF NUTRITION, 2006, 96 (03) :570-577